BioFreedom Pharmacokinetic Study

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

April 30, 2018

Study Completion Date

June 30, 2018

Conditions
Coronary Artery DiseaseMyocardial Infarction
Interventions
DEVICE

BioFreedom™ BA9™ drug-coated stent

Drug-coated stent for coronary arteries

Trial Locations (1)

Unknown

Hospital Clinic de Barcelona, Barcelona

All Listed Sponsors
lead

Biosensors Europe SA

INDUSTRY

NCT03365492 - BioFreedom Pharmacokinetic Study | Biotech Hunter | Biotech Hunter